| 8/13/2024 | BKHY | S&P elevates Crocs notes
|
| 2/16/2024 | BKHY | S&P upgrades Crocs, rates loan BBB-
|
| 1/19/2024 | CLHY | Market Commentary: HUB, Calpine, Crocs, Solenis, Autokiniton, Chamberlain, Cross, Warner, Kenan and more break
|
| 1/18/2024 | BKHY | Moody’s changes Crocs view
|
| 9/8/2023 | BKHY | S&P assigns BB to Crocs loan
|
| 8/3/2023 | CLHY | Market Commentary: Veritext, Crocs, Learning Care, Curium, Talen Energy, Duravant term loans break for trading
|
| 7/31/2023 | CLHY | Market Commentary: Fortress Investment breaks; LifePoint gains on paydown; Software AG changes surface
|
| 2/16/2023 | BKBWHYLM | Crocs focuses on deleveraging to 2x gross leverage ratio from 2.25x
|
| 1/11/2023 | BKBWHYLM | Crocs aims to cut leverage ratio to below 2x midway through next year
|
| 1/10/2023 | BKHY | S&P revises Crocs outlook to stable
|
| 12/12/2022 | BKBWHYLM | Crocs to de-lever below 2x after taking on debt for HeyDude purchase
|
| 1/27/2022 | CLHY | Market Commentary: Crocs, Embecta, Intelsat, Bausch Health, TaylorMade, athenahealth, Inspire Brands break
|
| 1/12/2022 | BKBWHY | Crocs expects 2x or under leverage by 2023; cash flow to repay debt
|
| 1/11/2022 | CLHY | Market Commentary: Cano Health, TricorBraun break; SRS Distribution revises pricing; Idera changes deadline
|
| 1/11/2022 | BKHY | S&P rates Crocs loan BB-, cuts notes
|
| 1/10/2022 | CLHY | Market Commentary: TricorBraun tweaks deal; Micro Focus, Griffon, Covis, Trac, Maravai, Simply disclose talk
|
| 1/10/2022 | BKHY | Moody’s rates Crocs loan Ba2
|
| 12/23/2021 | BKHY | Moody’s reviews Crocs for downgrade
|
| 12/23/2021 | BKHY | S&P places Crocs on watch
|
| 8/17/2021 | HY | Market Commentary: Morning Commentary: Junk opens lower; recent deals trade mixed; MultiPlan on deck
|
| 8/6/2021 | HY | Market Commentary: Bally’s, IEA price low-grade bonds; Ford in focus; Crocs at a premium; Cinemark gains
|
| 8/6/2021 | HY | Market Commentary: Morning Commentary: Ford maintains premium in active trading; Bally and IEA on deck
|
| 8/5/2021 | HY | Market Commentary: Two oversubscribed deals price in HY primary; Chemours struggles; funds lose $1.16 billion
|
| 8/5/2021 | HY | New Issue: Crocs prices $350 million 10-year notes at par to yield 4 1/8%
|
| 8/5/2021 | HY | Crocs driving by with $350 million 10-year notes, initial talk in 4 3/8% area
|
| 8/5/2021 | BKHY | S&P gives Crocs notes BB-
|
| 8/5/2021 | BKHY | Moody's assigns B1 to Crocs notes
|
| 3/10/2021 | HY | Market Commentary: AAdvantage prices, rips on the break; Avis at 102; Synaptics, Crocs, Mattel on par-handles
|
| 3/9/2021 | HY | New Issue: Crocs prices upsized $350 million eight-year notes at par to yield 4¼%
|
| 3/9/2021 | HY | Crocs talks $300 million eight-year notes to yield 4¼% to 4½%, pricing Tuesday
|
| 3/8/2021 | HY | Market Commentary: Charles River, Alcoa price; forward calendar grows; Playtika holds; Twilio active
|
| 3/8/2021 | HY | Crocs begins roadshow for $300 million eight-year notes, initial guidance 5% area
|
| 3/8/2021 | BKHY | Moody's rates Crocs Ba3, notes B1
|
| 3/8/2021 | BKHY | S&P assigns Crocs, notes BB-
|
